Literature DB >> 11911837

Association of dopamine D(3) receptors with actin-binding protein 280 (ABP-280).

Ming Li1, Chuanyu Li, Paul Weingarten, James R Bunzow, David K Grandy, Qun Yong Zhou.   

Abstract

Proteins that bind to G protein-coupled receptors have been identified as regulators of receptor localization and signaling. In our previous studies, a cytoskeletal protein, actin-binding protein 280 (ABP-280), was found to associate with the third cytoplasmic loop of dopamine D(2) receptors. In this study, we demonstrate that ABP-280 also interacts with dopamine D(3) receptors, but not with D(4) receptors. Similar to the dopamine D(2) receptor, the D(3)/ABP-280 association is of signaling importance. In human melanoma M2 cells lacking ABP-280, D(3) receptors were unable to inhibit forskolin-stimulated cyclic AMP (cAMP) production significantly. D(4) receptors, however, exhibited a similar degree of inhibition of forskolin-stimulated cAMP production in ABP-280-deficient M2 cells and ABP-280-replent M2 subclones (A7 cells). Further experiments revealed that the D(3)/ABP-280 interaction was critically dependent upon a 36 amino acid carboxyl domain of the D(3) receptor third loop, which is conserved in the D(2) receptor but not in the D(4) receptor. Our results demonstrate a subtype-specific regulation of dopamine D(2)-family receptor signaling by the cytoskeletal protein ABP-280.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11911837     DOI: 10.1016/s0006-2952(01)00932-7

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  11 in total

Review 1.  Regulation of G protein-coupled receptor export trafficking.

Authors:  Chunmin Dong; Catalin M Filipeanu; Matthew T Duvernay; Guangyu Wu
Journal:  Biochim Biophys Acta       Date:  2006-09-23

2.  The structure of the GPIb-filamin A complex.

Authors:  Fumihiko Nakamura; Regina Pudas; Outi Heikkinen; Perttu Permi; Ilkka Kilpeläinen; Adam D Munday; John H Hartwig; Thomas P Stossel; Jari Ylänne
Journal:  Blood       Date:  2005-11-17       Impact factor: 22.113

3.  The interaction between the mu opioid receptor and filamin A.

Authors:  Eric J Simon; Irma Onoprishvili
Journal:  Neurochem Res       Date:  2010-09-21       Impact factor: 3.996

Review 4.  Binding of pro-prion to filamin A: by design or an unfortunate blunder.

Authors:  C Li; W Xin; M-S Sy
Journal:  Oncogene       Date:  2010-08-09       Impact factor: 9.867

5.  Cyclic AMP-Rap1A signaling mediates cell surface translocation of microvascular smooth muscle α2C-adrenoceptors through the actin-binding protein filamin-2.

Authors:  Hanaa K B Motawea; Selvi C Jeyaraj; Ali H Eid; Srabani Mitra; Nicholas T Unger; Amany A E Ahmed; Nicholas A Flavahan; Maqsood A Chotani
Journal:  Am J Physiol Cell Physiol       Date:  2013-07-17       Impact factor: 4.249

6.  Novel interaction of the dopamine D2 receptor and the Ca2+ binding protein S100B: role in D2 receptor function.

Authors:  Yong Liu; David C Buck; Kim A Neve
Journal:  Mol Pharmacol       Date:  2008-04-29       Impact factor: 4.436

7.  Filamin A mutant lacking actin-binding domain restores mu opioid receptor regulation in melanoma cells.

Authors:  Irma Onoprishvili; Solav Ali; Matthew L Andria; Adam Shpigel; Eric J Simon
Journal:  Neurochem Res       Date:  2008-04-11       Impact factor: 3.996

8.  Filamin a binds to CCR2B and regulates its internalization.

Authors:  Laura Minsaas; Jesús Planagumà; Michael Madziva; Beate F Krakstad; Míriam Masià-Balagué; Arieh A Katz; Anna M Aragay
Journal:  PLoS One       Date:  2010-08-17       Impact factor: 3.240

Review 9.  Dopaminergic intracellular signal integrating proteins: relevance to schizophrenia.

Authors:  Bruno R Souza; Renan P Souza; Daniela V F Rosa; Melissa M Guimarães; Humberto Correa; Marco A Romano-Silva
Journal:  Dialogues Clin Neurosci       Date:  2006       Impact factor: 5.986

10.  Transcriptome alterations of mitochondrial and coagulation function in schizophrenia by cortical sequencing analysis.

Authors:  Kuo-Chuan Huang; Ko-Chun Yang; Han Lin; Theresa Tsun-Hui Tsao; Sheng-An Lee
Journal:  BMC Genomics       Date:  2014-12-08       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.